US Patent Issued to BIOGEN MA on Aug. 18 for "TYK2 inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,621, issued on Aug. 18, was assigned to BIOGEN MA INC. (Cambridge, Mass.).

"TYK2 inhibitors" was invented by Nathan Genung (Charlestown, Mass.) and Tamara Halkina Levin (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to compounds of formula (I'), or pharmaceutically acceptable salts thereof, in which all of the variables are as defined in the application. The compounds of the present disclosure are capable of inhibiting the activity of tyrosine kinase 2 (TYK2). The disclosure further provides methods of preparing the compounds of the disclosure, and methods for their therapeutic use."

The patent was filed on J...